The Sackler family and Purdue Pharma have agreed to a $7.4 billion settlement to resolve federal claims brought by attorneys ...

The Sackler family and Purdue Pharma, the maker of the addictive painkiller oxycontin, have reached a $7.4 billion settlement ...

Purdue Pharma and the Sackler family have agreed to pay over $7 billion for their role in the opioid crisis. Norah O'Donnell ...

The latest settlement is meant to address a drug addiction crisis that has led to over 700,000 opioid overdose deaths in the US over the past two decades.

The individuals behind Purdue Pharma’s involvement in the U.S. opioid crisis reached a $7-billion settlement in January 2025.

Pennsylvania stands to receive up to $212 million paid out by the family and company behind the nationwide saturation of ...

Purdue Pharma and the Sackler family who controlled it have agreed to pay up to $7.4bn (£6bn) to settle claims regarding its powerful prescription painkiller OxyContin. The deal represents an ...

Purdue Pharma and the Sackler families agreed Thursday to increase their financial contribution to $7.4 billion to resolve mass opioid litigation.

Pennsylvania expects to receive $212 million over 15 years as part of a multi-state settlement with the Sackler family, who ...

Purdue Pharma's earlier settlement plan included a $6 billion contribution from the Sacklers in exchange for immunity from all civil opioid claims.

A settlement reached with the Sackler family and Purdue Pharma will bring over $27 million to the First State, roughly half ...

Members of the family who own OxyContin maker Purdue Pharma ... The deal, agreed to by Purdue Pharma, the Sackler family members who own the company and lawyers representing state and local ...